ConductScience.org, home

Paper8024682

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

Fabry Z and 2 others. Immunol Today, 1994. Cited by 307 papers, by iCite.

Cite this record

ConductScience Library. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Papers, record 8024682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8024682

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.
PubMed
Journal
Immunol Today
PubMed
Year
1994
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
307
iCite
Relative citation ratio, by iCite
7.6
iCite
Revised in PubMed
2004-11-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fabry ZZ
2Raine CSC S
3Hart MNM N

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Central Nervous SystemMajor topic
Animals
Blood-Brain Barrier
Cell Adhesion Molecules
Cytokines
Humans
Major Histocompatibility Complex

Source PubMed

Download CSV of topics

Cited by69

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 307 citations.

PMIDTitleJournalYearIn PapersSource
39720231Myeloid antigen-presenting cells in neurodegenerative diseases: a focus on classical and non-classical MHC molecules.Front Neurosci2024https://conductscience.org/library/papers/39720231PubMed
39702579CAR-T cell therapy for the treatment of adult high-grade gliomas.NPJ Precis Oncol2024https://conductscience.org/library/papers/39702579PubMed
35116570Immunotherapy and radiation for high-grade glioma: a narrative review.Transl Cancer Res2021https://conductscience.org/library/papers/35116570PubMed
34953981Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE).J Control Release2022https://conductscience.org/library/papers/34953981PubMed
34764869Modulating Neurological Complications of Emerging Infectious Diseases: Mechanistic Approaches to Candidate Phytochemicals.Front Pharmacol2021https://conductscience.org/library/papers/34764869PubMed
34488748RNA sequencing analysis reveals the competing endogenous RNAs interplay in resected hepatocellular carcinoma patients who received interferon-alpha therapy.Cancer Cell Int2021https://conductscience.org/library/papers/34488748PubMed
31920929CTL-Derived Granzyme B Participates in Hippocampal Neuronal Apoptosis Induced by Cardiac Arrest and Resuscitation in Rats.Front Neurol2019https://conductscience.org/library/papers/31920929PubMed
28450947The inflammatory cytokine IL-22 promotes murine gliomas via proliferation.Exp Ther Med2017https://conductscience.org/library/papers/28450947PubMed
27182298Alterações Induzidas Pelo Exercício no Número, Função e Morfologia de Monócitos de Ratos.Int J Exerc Sci2008https://conductscience.org/library/papers/27182298PubMed
27182297Exercise Induced Alterations in Rat Monocyte Number, Morphology, and Function.Int J Exerc Sci2008https://conductscience.org/library/papers/27182297PubMed
25722935Immunotherapy for malignant glioma.Surg Neurol Int2015https://conductscience.org/library/papers/25722935PubMed
25577401Current challenges in designing GBM trials for immunotherapy.J Neurooncol2015https://conductscience.org/library/papers/25577401PubMed
25215607Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis.PLoS One2014https://conductscience.org/library/papers/25215607PubMed
23837761Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors.Future Oncol2013https://conductscience.org/library/papers/23837761PubMed
23737783Tumor-associated macrophages in glioma: friend or foe?J Oncol2013https://conductscience.org/library/papers/23737783PubMed
22190972Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Clin Dev Immunol2011https://conductscience.org/library/papers/22190972PubMed
21919736The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.J Interferon Cytokine Res2011https://conductscience.org/library/papers/21919736PubMed
21149252Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?Neuro Oncol2011https://conductscience.org/library/papers/21149252PubMed
20730616Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.J Neurooncol2011https://conductscience.org/library/papers/20730616PubMed
20300490Inflammation in adult and neonatal stroke.Clin Neurosci Res2006https://conductscience.org/library/papers/20300490PubMed

See all 69 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8024682

GET https://conductscience.org/api/papers/v1/8024682/cited_by?page=2